Immunoglobulin e (IGE) testing and associated services in support of the national health and nutrition examination survey (nhanes).
Ended Awarded Last action
- Contract number
- 75D30125F00210
- Awardee
-
Quest Diagnostics Incorporated UEI UC5SPMUJF8V3
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $960,620
Award facts
- Contract value 100% obligated
- $960,620.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Juan Capistrano, CA, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
Quest Diagnostics Incorporated, a leading clinical laboratory testing company headquartered in Secaucus, New Jersey, has been awarded a contract valued at $960,620 to provide Immunoglobulin E (IgE) testing and associated services in support of the National Health and Nutrition Examination Survey (NHANES). This contract is structured as a Blanket Purchase Agreement call under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) with firm fixed-price terms and an ultimate completion date of March 4, 2026. The work will be performed at Quest Diagnostics' facility in San Juan Capistrano, California. The award is not designated as a set-aside contract, indicating Quest Diagnostics competed through open procurement processes. The Centers for Disease Control and Prevention (CDC) Pittsburgh division is the funding federal agency.
The Centers for Disease Control and Prevention utilizes NHANES as its primary vehicle for assessing the health and nutritional status of the U.S. population through representative national surveys. Quest Diagnostics' delivery of IgE testing services supports NHANES' epidemiological data collection by providing laboratory analysis capabilities for immunological markers. This engagement reflects Quest Diagnostics' established role as a provider of specialized diagnostic testing to federal public health initiatives and aligns with the company's demonstrated capability in delivering reference laboratory services, infectious disease screening, and clinical laboratory analysis across multiple federal healthcare systems and research programs.
Quick answers
Who was awarded contract 75D30125F00210?
75D30125F00210 was awarded to Quest Diagnostics Incorporated by CDC Pittsburgh (Centers for Disease Control and Prevention) on March 20, 2025.
How much is contract 75D30125F00210 worth?
The government has obligated $960,620 on 75D30125F00210.
Is contract 75D30125F00210 an order under another contract?
Yes. 75D30125F00210 is a BPA call under V797D70090-75D30125A00181, a blanket purchase agreement, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 75D30125F00210 competed?
The extent of competition for 75D30125F00210 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award